BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 21177774)

  • 1. The new toxicology of sophisticated materials: nanotoxicology and beyond.
    Maynard AD; Warheit DB; Philbert MA
    Toxicol Sci; 2011 Mar; 120 Suppl 1(Suppl 1):S109-29. PubMed ID: 21177774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Historical overview of nanotechnology and nanotoxicology.
    Santamaria A
    Methods Mol Biol; 2012; 926():1-12. PubMed ID: 22975953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The primacy of physicochemical characterization of nanomaterials for reliable toxicity assessment: a review of the zebrafish nanotoxicology model.
    Bohnsack JP; Assemi S; Miller JD; Furgeson DY
    Methods Mol Biol; 2012; 926():261-316. PubMed ID: 22975971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. At the Crossroads of Nanotoxicology in vitro: Past Achievements and Current Challenges.
    Hussain SM; Warheit DB; Ng SP; Comfort KK; Grabinski CM; Braydich-Stolle LK
    Toxicol Sci; 2015 Sep; 147(1):5-16. PubMed ID: 26310852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles.
    Oberdörster G; Oberdörster E; Oberdörster J
    Environ Health Perspect; 2005 Jul; 113(7):823-39. PubMed ID: 16002369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotoxicity: the growing need for in vivo study.
    Fischer HC; Chan WC
    Curr Opin Biotechnol; 2007 Dec; 18(6):565-71. PubMed ID: 18160274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research strategies for safety evaluation of nanomaterials, part V: role of dissolution in biological fate and effects of nanoscale particles.
    Borm P; Klaessig FC; Landry TD; Moudgil B; Pauluhn J; Thomas K; Trottier R; Wood S
    Toxicol Sci; 2006 Mar; 90(1):23-32. PubMed ID: 16396841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The uncertainty of nanotoxicology: report of a Society for Risk Analysis Workshop.
    Canady RA
    Risk Anal; 2010 Nov; 30(11):1663-70. PubMed ID: 21070298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Safety of medicinal nanoproducts: new areas of toxicological research].
    Grudziński IP
    Rocz Panstw Zakl Hig; 2011; 62(3):239-46. PubMed ID: 22171512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered nanomaterial risk. Lessons learnt from completed nanotoxicology studies: potential solutions to current and future challenges.
    Johnston H; Pojana G; Zuin S; Jacobsen NR; Møller P; Loft S; Semmler-Behnke M; McGuiness C; Balharry D; Marcomini A; Wallin H; Kreyling W; Donaldson K; Tran L; Stone V
    Crit Rev Toxicol; 2013 Jan; 43(1):1-20. PubMed ID: 23126553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative Testing Strategies for Nanomaterials: State of the Science and Considerations for Risk Analysis.
    Shatkin JA; Ong KJ
    Risk Anal; 2016 Aug; 36(8):1564-80. PubMed ID: 27273523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of emerging concepts in nanotoxicology: opportunities and challenges for safer nanomaterial design.
    Singh AV; Laux P; Luch A; Sudrik C; Wiehr S; Wild AM; Santomauro G; Bill J; Sitti M
    Toxicol Mech Methods; 2019 Jun; 29(5):378-387. PubMed ID: 30636497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applied Nanotoxicology.
    Hobson DW; Roberts SM; Shvedova AA; Warheit DB; Hinkley GK; Guy RC
    Int J Toxicol; 2016; 35(1):5-16. PubMed ID: 26957538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomaterials in the environment: from materials to high-throughput screening to organisms.
    Thomas CR; George S; Horst AM; Ji Z; Miller RJ; Peralta-Videa JR; Xia T; Pokhrel S; Mädler L; Gardea-Torresdey JL; Holden PA; Keller AA; Lenihan HS; Nel AE; Zink JI
    ACS Nano; 2011 Jan; 5(1):13-20. PubMed ID: 21261306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bridging the divide between human and environmental nanotoxicology.
    Malysheva A; Lombi E; Voelcker NH
    Nat Nanotechnol; 2015 Oct; 10(10):835-44. PubMed ID: 26440721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem Cells, a New Generation Model for Predictive Nano Toxicological Assessment.
    Suma RN; Mohanan PV
    Curr Drug Metab; 2015; 16(10):932-9. PubMed ID: 26467070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of nanotoxicology: implications for drug delivery and medical devices.
    Bhattacharjee S; Brayden DJ
    Nanomedicine (Lond); 2015 Jul; 10(14):2289-305. PubMed ID: 26114880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research strategies for safety evaluation of nanomaterials, part II: toxicological and safety evaluation of nanomaterials, current challenges and data needs.
    Holsapple MP; Farland WH; Landry TD; Monteiro-Riviere NA; Carter JM; Walker NJ; Thomas KV
    Toxicol Sci; 2005 Nov; 88(1):12-7. PubMed ID: 16120754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology, nanotoxicology, and neuroscience.
    Suh WH; Suslick KS; Stucky GD; Suh YH
    Prog Neurobiol; 2009 Feb; 87(3):133-70. PubMed ID: 18926873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo methods of nanotoxicology.
    Greish K; Thiagarajan G; Ghandehari H
    Methods Mol Biol; 2012; 926():235-53. PubMed ID: 22975969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.